Clazakizumab Recruiting Phase 2 Trials for Asthma Treatment

Indications	Status	Purpose	Phase
DBCOND0013565 (Asthma)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04129931	PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study	Cavosonstat (DB14775) Clazakizumab (DB12849) Imatinib (DB00619) Medium-chain triglycerides (DB13959) OM85 (DB16533)